CDC authorise Pfizer boosters for 16- and 17-year-olds
The FDA and CDC have authorised booster vaccinations of the Pfizer-BioNTech COVID-19 vaccine for teenagers aged 16 and 17. The FDA expanded the EUA for Pfizer’s COVID-19 booster vaccination to include teenagers, six months after they have received the second shot of the vaccine. The move makes millions of teenagers eligible for an additional shot.
In November 2021, the FDA authorised a booster vaccine for emergency use in those aged 18 years and older, who had received primary vaccine series with the Pfizer-BioNTech series of other authorised shots, including Moderna and Johnson & Johnson. Nearly 50 million people in the US, around one quarter of those fully vaccinated, have received additional vaccines.
Lees dit artikel verder op: CDC authorise Pfizer boosters for 16- and 17-year-olds | Pharmafile
